Non-extractive procedure followed by LC/APCI MS/MS analysis of trimetazidine in plasma samples for assessing bioequivalence of immediate/modified release formulations
- 1 September 2005
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 19 (7), 549-555
- https://doi.org/10.1002/bmc.478
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- UTILITY OF SOME π-ACCEPTORS FOR THE SPECTROPHOTOMETRIC DETERMINATION OF TRIMETAZIDINE HYDROCHLORIDEAnalytical Letters, 2002
- HIGH THROUGHPUT ASSAY METHOD FOR THE QUANTITATION OF TRIMETAZIDINE IN HUMAN PLASMA BY LC/MS, WITH SELECTED REACTION MONITORINGJournal of Liquid Chromatography & Related Technologies, 2001
- Stability indicating HPTLC determination of Trimetazidine as bulk drug and in pharmaceutical formulationsJournal of Pharmaceutical and Biomedical Analysis, 2001
- Trimetazidine: stability indicating RPLC assay methodJournal of Pharmaceutical and Biomedical Analysis, 2001
- Analytical applications of chemiluminogenic reactionsAnalytica Chimica Acta, 2000
- The pH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis.Pharmaceutical Research, 1999
- Use of high-performance liquid chromatography with photodiode-array UV detection for the creation of a 600-compound library application to forensic toxicologyJournal of Chromatography A, 1997
- Identification of trimetazidine metabolites in human urine and plasmaXenobiotica, 1996
- Determination of trimetazidine in biological fluids by gas chromatography-mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Trace determination of trimetazidine in plasma by high-performance liquid chromatography using fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1981